NCT01579994 2020-12-30Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung CancersMemorial Sloan Kettering Cancer CenterPhase 1 Completed13 enrolled
NCT01183364 2014-09-19A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid TumorsSynta Pharmaceuticals Corp.Phase 1 Completed27 enrolled
NCT00687934 2014-09-18Study of STA-9090, Administered Once-Weekly in Patients With Solid TumorsSynta Pharmaceuticals Corp.Phase 1 Completed53 enrolled